DNA Oyj
DNA Plc's network infrastructure business arrangement completed
DNA Plc's network infrastructure business arrangement completed
DNA PLC STOCK EXCHANGE RELEASE 7 JANUARY 2025 AT 17:00 EET
DNA Plc's Finnish network infrastructure business, which is conducted by the company's subsidiary DNA Tower Finland Oy, has been transferred to Telenor Towers Finland Oy, a limited company established in the partial demerger of DNA, as of 1 January 2025. The change has also been registered in the Finnish Trade Register.
The arrangement was approved by DNA's shareholder on 13 November 2024, which was already announced by DNA on the date of approval.
This is an internal restructuring within Telenor Group and will not impact DNA’s operations.
Media enquiries:
DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi
DNA is one of the leading telecommunications companies in Finland. Our mission is to connect you to what matters most. We offer connections, services and devices for homes and workplaces, contributing to the digitalisation of society. DNA’s customers have been among the most active users of mobile data in the world for years. DNA has approximately 3.7 million subscriptions in its fixed and mobile communications networks. The company has been awarded numerous times as an excellent employer and family-friendly workplace. In 2023, our net sales were EUR 1,067 million. We employ about 1,700 people throughout Finland. DNA is part of Telenor Group, the leading telecommunications company in the Nordic countries. For more information, visit www.dna.fi or follow us on X @DNA_fi, Facebook @DNA.fi and LinkedIn @DNA-Oyj.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Sanoma Corp25.4.2025 17:30:00 CEST | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 April 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom